In October 2010, FDA approved dabigatran etexilate (Pradaxa, Boehringer Ingelheim), the first oral direct thrombin inhibitor for the prevention of thromboembolic stroke in patients with nonvalvular atrial fibrillation.
Medication therapy management is looking like the next new career opportunity for pharmacists as the Patient Protection and Affordable Care Act, health plans, and employers press for its adoption.
Despite the barriers to provision of MTM that exist for pharmacists, figuring out a way to do it is our professional obligation.
New data show that while nearly all MI patients receive beta blockers, most patients receive suboptimal doses that are never increased.
Drug Topics' annual business outlook survey, conducted online in October, drew more than 400 responses from community, hospital, and long-term-care pharmacists. Their conclusions about the coming year may surprise you.
Wanna get something off your chest? Drug Topics readers have a new forum in which to share their thoughts with their peers. To join the conversation, e-mail your submission to [email protected].
Kathleen Jaeger's appointment as executive vice president and CEO of the NCPA was announced October 25 at the association's annual Convention and Trade Expo in Philadelphia.
The pharmacist sitting in the office is interested in squeezing out another penny per prescription. The pharmacist behind the locked gate is interested in going home before midnight. Both cannot happen. A side must be chosen.
Lack of patient awareness coupled with ballooning numbers of diabetes cases across the United States have impelled pharmacies and organization to make diabetes care and education a priority.
Jon Roth, who has 20 years' experience in healthcare and healthcare association management, will begin his new role as CEO of the California Pharmacists Association on Nov. 22.